Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies

MLA

Xiaofan Lu, et al. “Multi‐omics Consensus Ensemble Refines the Classification of Muscle‐invasive Bladder Cancer with Stratified Prognosis, Tumour Microenvironment and Distinct Sensitivity to Frontline Therapies.” Clinical and Translational Medicine, vol. 11, no. 12, Dec. 2021. EBSCOhost, https://doi.org/10.1002/ctm2.601.

APA

Xiaofan Lu, Jialin Meng, Liwen Su, Liyun Jiang, Haitao Wang, Junkai Zhu, Mengjia Huang, Wenxuan Cheng, Li Xu, Xinjia Ruan, Shuyuan Yeh, Chaozhao Liang, & Fangrong Yan. (2021). Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies. Clinical and Translational Medicine, 11(12). https://doi.org/10.1002/ctm2.601

Chicago

Xiaofan Lu, Jialin Meng, Liwen Su, Liyun Jiang, Haitao Wang, Junkai Zhu, Mengjia Huang, et al. 2021. “Multi‐omics Consensus Ensemble Refines the Classification of Muscle‐invasive Bladder Cancer with Stratified Prognosis, Tumour Microenvironment and Distinct Sensitivity to Frontline Therapies.” Clinical and Translational Medicine 11 (12). doi:10.1002/ctm2.601.